Nuwellis Launches South Texas Territory to Boost Aquadex Therapy Engagement
Nuwellis has established a dedicated South Texas commercial territory to provide direct clinical support for Aquadex therapy across major hospital systems and cardiac care programs. The expansion aims to deepen engagement with physicians and care teams managing complex fluid balance in cardiorenal patients.
1. Dedicated South Texas Territory
Nuwellis has created a new commercial territory covering major hospital systems in South Texas, focusing on leading cardiac and critical care programs managing patients with complex fluid balance challenges. This move is designed to increase institutional access to Aquadex ultrafiltration therapy.
2. Direct Clinical Engagement
The company will deploy specialized field teams to deliver hands-on training and clinical support, enabling physicians and care teams to evaluate and implement precise fluid management strategies for cardiorenal patients unresponsive to diuretics.
3. Commercial Infrastructure Strengthening
This strategic expansion aligns with Nuwellis’ broader effort to enhance its U.S. commercial organization, accelerate market penetration in key healthcare regions and support adoption of its cardiorenal solutions across acute and chronic care settings.